Clinical trial
Study of Apatinib as the Maintenance Therapy in Advanced Lung Adenocarcinoma
NCT03376737
Study timeline
Study start (actual)2017-10-12Date precision: day
Registry last updated2017-12-18
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Adenocarcinomaunresolved
Interventions
ApatinibDRUG
Sponsors & collaborators
Henan Cancer Hospitallead sponsor
Jiangsu HengRui Medicine Co., Ltd.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03376737 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.